Effect of DPP4 Inhibition on Growth Hormone Secretion

NCT01701973 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Sitagliptin
DRUG: Pegvisomant
DRUG: Placebo
DRUG: L-NMMA
DRUG: Exendin 9-39

Sponsor

Vanderbilt University

Collaborators

[object Object]
[object Object]